πŸ‡ΊπŸ‡Έ FDA
Patent

US 9359290

Treatment of cataplexy

granted A61KA61K31/27A61K31/325

Quick answer

US patent 9359290 (Treatment of cataplexy) held by Jazz Pharmaceuticals International III Limited expires Mon Jun 02 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Jazz Pharmaceuticals International III Limited
Grant date
Tue Jun 07 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 02 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
22
CPC classes
A61K, A61K31/27, A61K31/325, A61K45/06, A61K9/0053